AFFF cost per signed retainer
AFFF (firefighting foam, PFAS cancer) carries a cost per signed retainer of $2,800–$4,200 in Q1 2026, current as of March 31, 2026, at a 9–14% signed rate and a high qualification tier. Litigation status (verified November 17, 2026): active federal mdl. Sample size and confidence interval for this row are not available; the reason is stated on each figure below rather than omitted.
Data as of Updated Q1 2026 releaseLatest published release; the next quarterly release has not been published yet
AFFF litigation status & sources
Active federal MDLStatus verified on against primary sources · next check due
As of Nov 2026, MDL 2873 in the District of South Carolina remains open with 15,270 pending actions. On Nov 3, 2026, 3M announced an agreement to resolve most personal injury claims against 3M; claims against other defendants are not included.
- Proceeding
- MDL 2873 (D.S.C.)
- Richard M. Gergel
- Pending actions
- 15,270
- JPML Pending MDL Dockets by District, report date 11/2/2026
Key dates
- Case Management Order No. 1 consolidated AFFF cases before Judge Gergel in the District of South Carolina.
- 3M announced a $7.35 billion nominal (about $5.8 billion present value) resolution covering about 99% of current personal injury claims against 3M, contingent on plaintiff participation.
Sources
- JPMLJPML Pending MDL Dockets by District (Nov 2, 2026)
- CourtD.S.C. MDL 2873 In re: Aqueous Film-Forming Foams Products Liability Litigation
- Government3M Reaches Broad Resolution of AFFF Personal Injury Litigation (3M press release, SEC Form 8-K exhibit)
Marketing information for law firms, not legal advice. Litigation status changes; confirm filing posture, case criteria and deadlines with counsel before launching or continuing a campaign. How we source and date this: editorial standards.
CPR range · Q1 2026
$2,800 – $4,200
Median: n/a — Per-tort medians are not published. The dataset carries the interquartile low and high bounds for each tort; only the national median is published as a point value.
Signed rate
9–14%
Share of exclusive leads that become signed retainers.
Qualification tier
High
Relative difficulty of clearing this tort's qualifying criteria.
Litigation status
Active federal MDL
Verified November 17, 2026 against primary sources.
Sample size
n/a
Per-tort sample sizes are not broken out in the published dataset. The panel total (140 firms, $180M of annual mass tort lead spend across 16 active tort categories) is published at the panel level only, so the number of firms and the spend basis behind any single row cannot be stated.
Confidence interval
n/a
Not computable from the published dataset. Benchmarks are published as trimmed interquartile ranges, and the per-observation values a confidence interval requires are not retained in the published figures.
Unverified
No third party has reviewed this methodology or the underlying data. Mass Tort Marketing Agency sells the leads these figures price.
What third-party verification would involveAFFF CPR over time
The series for AFFF starts at Q1 2026. Mass Tort Marketing Agency holds one published quarter of per-tort data for this tort, so there is no trend line to draw yet — the single point is shown below, and a second point will appear when the next quarter publishes.
| Quarter | CPR low | CPR high | Note |
|---|---|---|---|
| Q4 2024 | n/a | n/a | No per-tort breakdown for Q4 2024 is held in the dataset. Only the national median is held for that quarter, which is why the per-tort trend series begins at Q1 2026. |
| Q1 2026 | $2,800 | $4,200 | Published. |
What qualifies a AFFF claimant
Documented occupational exposure to aqueous film-forming foam containing PFAS compounds — professional firefighters, military firefighting personnel, and industrial-site workers — plus a qualifying cancer diagnosis (testicular, kidney, or certain lymphomas, depending on the MDL's current inclusion list).
Falloff: n/a — Not published for this tort. The source dataset does not state a numeric falloff range for AFFF.
Active — what that means for acquisition
Active. TCPA compliance matters more here than in any other tort in the benchmark because the claimant pool overlaps with active-duty and retired-military populations regulated under the Military Lending Act and related federal statutes. Firms buying non-compliant AFFF leads carry materially higher downstream litigation risk than in consumer torts, which makes the 15-25% premium for consent-verified AFFF leads arguably the most defensible in the benchmark.
AFFF cost per lead
This dataset does not publish a cost-per-lead figure for AFFF, and no CPL value is shown here rather than being derived from the CPR band. The two are related by the signed rate — CPL is approximately CPR × signed rate — but running that multiplication against a published interquartile band produces a number that looks measured and is not, so it is left out. What the benchmark does state is the signed rate: 9–14% of exclusive AFFF leads become signed retainers that survive the 30-day falloff window. If you have your own CPL from a vendor quote, that signed rate is the multiplier that turns it into a comparable CPR.
Download this row
How to cite this page
Suggested citation:
Mass Tort Marketing Agency. "AFFF (firefighting foam, PFAS cancer) cost per signed retainer." Q1 2026 CPR Benchmark, published April 24, 2026. https://www.masstortmarketingagency.com/benchmarks/afff
- Canonical URL:
- https://www.masstortmarketingagency.com/benchmarks/afff
- License:
- CC BY 4.0 — reuse permitted with attribution to Mass Tort Marketing Agency CPR Benchmark, https://www.masstortmarketingagency.com/benchmarks/
Citing a number that must stay stable? Point at a dated snapshot instead of the live page — snapshot files never change.
